SC

Suresh Chhabildas Shah

Active Director Director DIN 00477470
DIN 00477470 First appointment Aug 1982 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Aug 1982
Shareholding value •••• Premium profile

About Suresh Chhabildas Shah

Data last updated:

Suresh Chhabildas Shah is a Director at Mepro Pharmaceuticals Private Limited (since 1982) and Whole-Time Director at Mepromax Life Sciences Private Limited (since 2006). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹439 Cr; the largest is Mepro Pharmaceuticals Private Limited at ₹356 Cr (FY 2025). Earlier, Suresh Chhabildas Shah was a Director at Bdr Pharmaceuticals International Private Limited (2004–2011) and Director at Midland Pharmaceuticals Private Limited (from 1987).

DIN 00477470
Primary Designation Director
Industry Pharma
First Appointment 31 Aug 1982
Oldest Company Age 44 yrs
Largest company Mepro Pharmaceuticals Private Limited · ₹356 Cr (FY 2025)
Combined revenue ₹439 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Aug 19821982₹356 Cr (FY 2025)Active
Whole-Time Director15 Jun 20062005₹82.29 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jan 20042002₹1,137 Cr (FY 2025)Active
Director17 Aug 19871987Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mepro Pharmaceuticals Private Limited
Midland Pharmaceuticals Private Limited
Mepromax Life Sciences Private Limited
Bdr Pharmaceuticals International Private Limited
Premium access

Shareholding and investment profile for Suresh Chhabildas Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Chhabildas Shah

Suresh Chhabildas Shah currently holds 2 directorships: Mepro Pharmaceuticals Private Limited (Director, since 31 Aug 1982, revenue ₹356 Cr (FY 2025)); Mepromax Life Sciences Private Limited (Whole-Time Director, since 15 Jun 2006, revenue ₹82.29 Cr (FY 2025)).

Suresh Chhabildas Shah was first appointed on 31 Aug 1982 as Director at Mepro Pharmaceuticals Private Limited. The most recent appointment on record is 15 Jun 2006 at Mepromax Life Sciences Private Limited.

The 2 current companies of Suresh Chhabildas Shah that report revenue have a combined latest revenue of ₹439 Cr: Mepro Pharmaceuticals Private Limited ₹356 Cr (FY 2025); Mepromax Life Sciences Private Limited ₹82.29 Cr (FY 2025).

Suresh Chhabildas Shah held 2 earlier board appointments: Bdr Pharmaceuticals International Private Limited (Director, 05 Jan 2004 to 27 Jul 2011); Midland Pharmaceuticals Private Limited (Director, from 17 Aug 1987).

The current boards of Suresh Chhabildas Shah's companies include Bharatkumar Chabildas Shah (Mepro Pharmaceuticals Private Limited), Prakash Navinchandra Shah (Mepro Pharmaceuticals Private Limited), Rajesh Sumanlal Shah (Mepro Pharmaceuticals Private Limited), Vijay Chhabildas Shah (Mepro Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available